Lee is the National Life Sciences Advisory Leader for Grant Thornton. He is a seasoned life sciences executive with more than 15 years of experience in strategic and operational capacities in both consulting and industry roles. He is a corporate strategist with a practical approach to link strategy to execution through visibility to measurable metrics and accountability for results. Lee is also a proven consulting leader with a track record of building high performing Life Sciences consulting teams. He has been a thought leader dedicated to the idea that life sciences companies need to rethink their role in the healthcare ecosystem and move “beyond the pill” to drive patient outcomes through innovative solutions in collaboration with payers and providers.
Prior to Grant Thornton, Lee was Executive Vice President of Corporate Strategic Development for Mylan, Inc., a Fortune 500 specialty pharmaceutical manufacturer. In this role, he was responsible globally for Corporate Strategy, Business Transformation, Business Analytics, and Health Innovation Solutions. Prior to this role, Lee held positions of increasing responsibility with PricewaterhouseCoopers and IBM Global Business Services where he was a Partner and led the Strategy and Transformation practice for Life Sciences in North America.
Lee has worked with both large and emerging pharmaceutical companies to plan for and execute transformational programs. His areas of focus include Corporate Strategy, Sales and Marketing, Managed Markets, and functional transformations in HR, Finance, Legal, and IT. He has also worked with a number of clients to develop strategies and implement solutions in compliance, including Aggregate Spend reporting solutions, process and policy solutions for dealing with third-party vendors (such as speaker programs), and strategies to meet additional compliance requirements that resulted from Corporate Integrity Agreements.